Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands—a Holistic Approach-Reference-Cited by-同舟云学术

Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands—a Holistic Approach

Published:2024-02-16 Issue:3 Volume:13 Page:481-499
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Zeevat Florian^ORCID,Simons Joost J. M.^ORCID,Westra Tjalke A.^ORCID,Wilschut Jan C.^ORCID,van Sorge Nina M.^ORCID,Boersma Cornelis^ORCID,Postma Maarten J.^ORCID

Funder

GlaxoSmithKline Biologicals

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40121-023-00903-0.pdf

Reference42 articles.

1. European Centre for Disease Prevention and Control. Factsheet about meningococcal disease 2019. Available from: https://www.ecdc.europa.eu/en/meningococcal-disease/factsheet. (accessed on: Oct 26, 2021)

2. Olbrich KJ, Müller D, Schumacher S, Beck E, Meszaros K, Koerber F. Systematic review of invasive meningococcal disease: sequelae and quality of life impact on patients and their caregivers. Infect Dis Ther. 2018;7(4):421–38.

3. Koelman DLH, van Kassel MN, Bijlsma MW, Brouwer MC, van de Beek D, van der Ende A. Changing epidemiology of bacterial meningitis since introduction of conjugate vaccines: 3 decades of national meningitis surveillance in The Netherlands. Clin Infect Dis. 2021;73(5):e1099–107.

4. Control ECfDPa. Invasive meningococcal disease. Annual epidemiological report for 2017. 2016. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/AER_for_2017-invasive-meningococcal-disease.pdf. (accessed on: Jan 25, 2022)

5. Krone M, Gray S, Abad R, et al. Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017. Euro Surveill. 2019. https://doi.org/10.2807/1560-7917.ES.2019.24.14.1800245.